In a major positive development in the global fight against novel coronavirus, Russia has become the first nation to have completed the world's first-ever clinical trial of a potential COVID-19 vaccine candidate on humans.
India To Release 1st Covid Vaccine By Aug 15
Indian council of Medical Research (ICMR) wants to launch indigenous vaccine for COVID-19 by August 15.
Indian council of Medical Research (ICMR) wants to launch indigenous vaccine for COVID-19 by August 15.
‘Amidst the world reeling under the detrimental effects of the novel coronavirus pandemic attack, Russia brought hope to humankind as it successfully completed the first clinical trials of the COVID-19 vaccine on humans.
’
"The research has been completed, and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20," Smolyarchuk was quoted as saying in the report. There was, however, no further information on when this vaccine would enter the commercial production stage.
Russia had allowed clinical trials of two forms of a potential Covid-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology on June 18.
Nearly 60 to 70 Percent Population Will Get COVID-19 Without Vaccine
COVID-19 outbreak won't end until 60-70 percent of the human population is immune to the novel coronavirus, as it may take between 18 and 24 months to develop a vaccine for it, says a Public Health Professor of Johns Hopkins University in the USA.
COVID-19 outbreak won't end until 60-70 percent of the human population is immune to the novel coronavirus, as it may take between 18 and 24 months to develop a vaccine for it, says a Public Health Professor of Johns Hopkins University in the USA.
Another vaccine, in the form of a powder for the preparation of a solution for intramuscular administration, was carried out at Sechenov First Moscow State Medical University.
Advertisement
COVID-19 Vaccine Development: Fresh Insights
New study has shed light on the COVID-19 vaccine development. The key discovery provides crucial leads for guiding experimental efforts towards the vaccine development against the novel pneumonia (COVID-19) caused by the virus.
New study has shed light on the COVID-19 vaccine development. The key discovery provides crucial leads for guiding experimental efforts towards the vaccine development against the novel pneumonia (COVID-19) caused by the virus.
After vaccination, all volunteers were expected to remain in isolation in a hospital for 28 days.
Advertisement
Should ACEI and ARB be Prescribed During the COVID-19 Pandemic?
ACEI and ARB is presumed to be unsafe for use during the COVID-19 pandemic as these could increase the risk of infection. However, leading global health authorities recommend their use.
ACEI and ARB is presumed to be unsafe for use during the COVID-19 pandemic as these could increase the risk of infection. However, leading global health authorities recommend their use.
"The data obtained by the Gamalei National Research Center for Epidemiology and Microbiology proves that volunteers of the first and second groups are forming an immune response after injections of the vaccine against the coronavirus," according to an earlier statement from the Russian Defense Ministry.
Russia has reported 719,449 cases and 11,188 deaths to date.
There are at least 21 vaccines currently under key trials, according to the World Health Organisation (WHO).
According to Johns Hopkins University in the US, the overall number of global COVID-19 cases was nearing 12.7 million, while the deaths have increased to more than 564,000.
As of Sunday morning, the total number of cases stood at 12,681,472, while the fatalities rose to 564,420.
The US accounted for the world's highest number of infections and fatalities at 3,245,158 and 134,764. Brazil came in second place, with 1,839,850 infections and 71,469 deaths.
Source-IANS
